UniProt ID | LASP1_HUMAN | |
---|---|---|
UniProt AC | Q14847 | |
Protein Name | LIM and SH3 domain protein 1 | |
Gene Name | LASP1 | |
Organism | Homo sapiens (Human). | |
Sequence Length | 261 | |
Subcellular Localization | Cytoplasm, cell cortex. Cytoplasm, cytoskeleton. Associated with the F-actin rich cortical cytoskeleton.. | |
Protein Description | Plays an important role in the regulation of dynamic actin-based, cytoskeletal activities. Agonist-dependent changes in LASP1 phosphorylation may also serve to regulate actin-associated ion transport activities, not only in the parietal cell but also in certain other F-actin-rich secretory epithelial cell types (By similarity).. | |
Protein Sequence | MNPNCARCGKIVYPTEKVNCLDKFWHKACFHCETCKMTLNMKNYKGYEKKPYCNAHYPKQSFTMVADTPENLRLKQQSELQSQVRYKEEFEKNKGKGFSVVADTPELQRIKKTQDQISNIKYHEEFEKSRMGPSGGEGMEPERRDSQDGSSYRRPLEQQQPHHIPTSAPVYQQPQQQPVAQSYGGYKEPAAPVSIQRSAPGGGGKRYRAVYDYSAADEDEVSFQDGDTIVNVQQIDDGWMYGTVERTGDTGMLPANYVEAI | |
Overview of Protein Modification Sites with Functional and Structural Information | ||
|
* ASA = Accessible Surface Area
Locations | Modification | Substrate Peptides & Secondary Structure |
ASA (%) | Reference | Orthologous Protein Cluster |
---|---|---|---|---|---|
1 | Acetylation | -------MNPNCARC -------CCCCCCCC | 19.88 | 12665801 | |
10 | Ubiquitination | PNCARCGKIVYPTEK CCCCCCCCEECCCCC | 32.40 | - | |
10 (in isoform 2) | Ubiquitination | - | 32.40 | - | |
13 | Phosphorylation | ARCGKIVYPTEKVNC CCCCCEECCCCCCCC | 14.12 | 28152594 | |
15 | Phosphorylation | CGKIVYPTEKVNCLD CCCEECCCCCCCCHH | 30.65 | 28152594 | |
17 | Acetylation | KIVYPTEKVNCLDKF CEECCCCCCCCHHHH | 41.02 | 23954790 | |
17 | Malonylation | KIVYPTEKVNCLDKF CEECCCCCCCCHHHH | 41.02 | 26320211 | |
17 | Ubiquitination | KIVYPTEKVNCLDKF CEECCCCCCCCHHHH | 41.02 | - | |
17 (in isoform 2) | Ubiquitination | - | 41.02 | - | |
23 | Acetylation | EKVNCLDKFWHKACF CCCCCHHHHHHHHHH | 37.09 | 25825284 | |
23 | Ubiquitination | EKVNCLDKFWHKACF CCCCCHHHHHHHHHH | 37.09 | 21890473 | |
23 (in isoform 1) | Ubiquitination | - | 37.09 | 21890473 | |
23 (in isoform 2) | Ubiquitination | - | 37.09 | 21890473 | |
27 | Acetylation | CLDKFWHKACFHCET CHHHHHHHHHHCCCC | 37.13 | 26051181 | |
31 | Ubiquitination | FWHKACFHCETCKMT HHHHHHHCCCCCCEE | 14.37 | - | |
34 | Phosphorylation | KACFHCETCKMTLNM HHHHCCCCCCEEECC | 23.87 | 28258704 | |
36 | Acetylation | CFHCETCKMTLNMKN HHCCCCCCEEECCCC | 42.19 | 26051181 | |
38 | Phosphorylation | HCETCKMTLNMKNYK CCCCCCEEECCCCCC | 10.65 | 23403867 | |
40 | Ubiquitination | ETCKMTLNMKNYKGY CCCCEEECCCCCCCC | 30.16 | 21890473 | |
42 | Acetylation | CKMTLNMKNYKGYEK CCEEECCCCCCCCCC | 56.93 | 19608861 | |
42 | Malonylation | CKMTLNMKNYKGYEK CCEEECCCCCCCCCC | 56.93 | 26320211 | |
42 | Ubiquitination | CKMTLNMKNYKGYEK CCEEECCCCCCCCCC | 56.93 | 21906983 | |
42 (in isoform 1) | Ubiquitination | - | 56.93 | 21890473 | |
42 (in isoform 2) | Ubiquitination | - | 56.93 | 21890473 | |
44 | Phosphorylation | MTLNMKNYKGYEKKP EEECCCCCCCCCCCC | 10.56 | 20068231 | |
45 | Succinylation | TLNMKNYKGYEKKPY EECCCCCCCCCCCCC | 65.49 | 23954790 | |
45 | Ubiquitination | TLNMKNYKGYEKKPY EECCCCCCCCCCCCC | 65.49 | - | |
47 | Phosphorylation | NMKNYKGYEKKPYCN CCCCCCCCCCCCCCC | 22.03 | - | |
49 | Acetylation | KNYKGYEKKPYCNAH CCCCCCCCCCCCCCC | 51.03 | 26051181 | |
50 | Acetylation | NYKGYEKKPYCNAHY CCCCCCCCCCCCCCC | 29.31 | 26822725 | |
50 | Ubiquitination | NYKGYEKKPYCNAHY CCCCCCCCCCCCCCC | 29.31 | - | |
52 | Phosphorylation | KGYEKKPYCNAHYPK CCCCCCCCCCCCCCC | 13.76 | 28152594 | |
57 | Phosphorylation | KPYCNAHYPKQSFTM CCCCCCCCCCCCEEE | 15.09 | 28152594 | |
59 | Acetylation | YCNAHYPKQSFTMVA CCCCCCCCCCEEEEE | 51.94 | 26051181 | |
59 | Malonylation | YCNAHYPKQSFTMVA CCCCCCCCCCEEEEE | 51.94 | 26320211 | |
59 | Ubiquitination | YCNAHYPKQSFTMVA CCCCCCCCCCEEEEE | 51.94 | - | |
59 (in isoform 2) | Ubiquitination | - | 51.94 | - | |
61 | Phosphorylation | NAHYPKQSFTMVADT CCCCCCCCEEEEECC | 28.89 | 30266825 | |
63 | Phosphorylation | HYPKQSFTMVADTPE CCCCCCEEEEECCHH | 18.91 | 30266825 | |
64 | Sulfoxidation | YPKQSFTMVADTPEN CCCCCEEEEECCHHH | 1.89 | 21406390 | |
65 | Acetylation | PKQSFTMVADTPENL CCCCEEEEECCHHHH | 3.86 | - | |
65 | Ubiquitination | PKQSFTMVADTPENL CCCCEEEEECCHHHH | 3.86 | 21890473 | |
68 | Phosphorylation | SFTMVADTPENLRLK CEEEEECCHHHHHHH | 23.82 | 29255136 | |
72 | Ubiquitination | VADTPENLRLKQQSE EECCHHHHHHHHHHH | 6.91 | - | |
75 | Sumoylation | TPENLRLKQQSELQS CHHHHHHHHHHHHHH | 39.60 | - | |
75 | Malonylation | TPENLRLKQQSELQS CHHHHHHHHHHHHHH | 39.60 | 26320211 | |
75 | Methylation | TPENLRLKQQSELQS CHHHHHHHHHHHHHH | 39.60 | 24129315 | |
75 | Sumoylation | TPENLRLKQQSELQS CHHHHHHHHHHHHHH | 39.60 | - | |
75 | Ubiquitination | TPENLRLKQQSELQS CHHHHHHHHHHHHHH | 39.60 | - | |
75 (in isoform 1) | Ubiquitination | - | 39.60 | 21890473 | |
75 (in isoform 2) | Ubiquitination | - | 39.60 | 21890473 | |
78 | Phosphorylation | NLRLKQQSELQSQVR HHHHHHHHHHHHHHH | 37.47 | 21406692 | |
82 | Phosphorylation | KQQSELQSQVRYKEE HHHHHHHHHHHHHHH | 43.18 | 25159151 | |
86 | Phosphorylation | ELQSQVRYKEEFEKN HHHHHHHHHHHHHHH | 24.72 | 21406692 | |
87 | Sumoylation | LQSQVRYKEEFEKNK HHHHHHHHHHHHHHC | 39.96 | - | |
87 | Sumoylation | LQSQVRYKEEFEKNK HHHHHHHHHHHHHHC | 39.96 | - | |
87 | Ubiquitination | LQSQVRYKEEFEKNK HHHHHHHHHHHHHHC | 39.96 | - | |
92 | Acetylation | RYKEEFEKNKGKGFS HHHHHHHHHCCCCEE | 70.09 | 30583743 | |
92 | Methylation | RYKEEFEKNKGKGFS HHHHHHHHHCCCCEE | 70.09 | 30583743 | |
96 | Acetylation | EFEKNKGKGFSVVAD HHHHHCCCCEEEEEC | 59.39 | 26051181 | |
96 | Malonylation | EFEKNKGKGFSVVAD HHHHHCCCCEEEEEC | 59.39 | 26320211 | |
96 | Ubiquitination | EFEKNKGKGFSVVAD HHHHHCCCCEEEEEC | 59.39 | - | |
96 (in isoform 1) | Ubiquitination | - | 59.39 | 21890473 | |
96 (in isoform 2) | Ubiquitination | - | 59.39 | 21890473 | |
99 | Phosphorylation | KNKGKGFSVVADTPE HHCCCCEEEEECCHH | 25.09 | 29255136 | |
104 | Phosphorylation | GFSVVADTPELQRIK CEEEEECCHHHHHHH | 14.66 | 19664994 | |
112 | Succinylation | PELQRIKKTQDQISN HHHHHHHHCHHHHHC | 49.39 | - | |
112 | Succinylation | PELQRIKKTQDQISN HHHHHHHHCHHHHHC | 49.39 | - | |
112 | Ubiquitination | PELQRIKKTQDQISN HHHHHHHHCHHHHHC | 49.39 | - | |
113 | Phosphorylation | ELQRIKKTQDQISNI HHHHHHHCHHHHHCC | 32.17 | 23312004 | |
118 | Phosphorylation | KKTQDQISNIKYHEE HHCHHHHHCCHHHHH | 27.20 | 25159151 | |
121 | Acetylation | QDQISNIKYHEEFEK HHHHHCCHHHHHHHH | 44.82 | 23954790 | |
121 | Ubiquitination | QDQISNIKYHEEFEK HHHHHCCHHHHHHHH | 44.82 | 21890473 | |
121 (in isoform 1) | Ubiquitination | - | 44.82 | 21890473 | |
121 (in isoform 2) | Ubiquitination | - | 44.82 | 21890473 | |
122 | Phosphorylation | DQISNIKYHEEFEKS HHHHCCHHHHHHHHH | 15.63 | 28102081 | |
128 | Acetylation | KYHEEFEKSRMGPSG HHHHHHHHHHCCCCC | 49.00 | 19608861 | |
128 | Methylation | KYHEEFEKSRMGPSG HHHHHHHHHHCCCCC | 49.00 | 22640041 | |
128 | Ubiquitination | KYHEEFEKSRMGPSG HHHHHHHHHHCCCCC | 49.00 | - | |
129 | Phosphorylation | YHEEFEKSRMGPSGG HHHHHHHHHCCCCCC | 21.94 | 28857561 | |
131 | Acetylation | EEFEKSRMGPSGGEG HHHHHHHCCCCCCCC | 13.78 | - | |
134 | Phosphorylation | EKSRMGPSGGEGMEP HHHHCCCCCCCCCCC | 54.42 | 23927012 | |
146 | Phosphorylation | MEPERRDSQDGSSYR CCCCCCCCCCCCCCC | 28.49 | 29255136 | |
150 | Phosphorylation | RRDSQDGSSYRRPLE CCCCCCCCCCCCCHH | 32.27 | 22167270 | |
151 | Phosphorylation | RDSQDGSSYRRPLEQ CCCCCCCCCCCCHHH | 28.34 | 21945579 | |
152 | Phosphorylation | DSQDGSSYRRPLEQQ CCCCCCCCCCCHHHC | 16.61 | 21945579 | |
166 | O-linked_Glycosylation | QQPHHIPTSAPVYQQ CCCCCCCCCCCCCCC | 36.60 | OGP | |
166 | Phosphorylation | QQPHHIPTSAPVYQQ CCCCCCCCCCCCCCC | 36.60 | 21945579 | |
167 | Phosphorylation | QPHHIPTSAPVYQQP CCCCCCCCCCCCCCC | 25.81 | 21945579 | |
171 | Phosphorylation | IPTSAPVYQQPQQQP CCCCCCCCCCCCCCC | 10.60 | 21945579 | |
182 | Phosphorylation | QQQPVAQSYGGYKEP CCCCCHHHCCCCCCC | 18.92 | 21945579 | |
183 | Phosphorylation | QQPVAQSYGGYKEPA CCCCHHHCCCCCCCC | 11.50 | 21945579 | |
186 | Phosphorylation | VAQSYGGYKEPAAPV CHHHCCCCCCCCCCC | 14.07 | 21945579 | |
187 | Acetylation | AQSYGGYKEPAAPVS HHHCCCCCCCCCCCE | 61.57 | 23236377 | |
187 | Ubiquitination | AQSYGGYKEPAAPVS HHHCCCCCCCCCCCE | 61.57 | - | |
194 | Phosphorylation | KEPAAPVSIQRSAPG CCCCCCCEEEECCCC | 16.37 | 26356563 | |
198 | Phosphorylation | APVSIQRSAPGGGGK CCCEEEECCCCCCCC | 23.57 | 25159151 | |
205 | Acetylation | SAPGGGGKRYRAVYD CCCCCCCCEEEEEEE | 49.91 | 22362455 | |
241 | Phosphorylation | QIDDGWMYGTVERTG ECCCCEEEEEEEECC | 11.79 | - | |
247 | Phosphorylation | MYGTVERTGDTGMLP EEEEEEECCCCCCEE | 26.38 | 22617229 | |
252 | Sulfoxidation | ERTGDTGMLPANYVE EECCCCCCEEHHHEE | 4.38 | 30846556 | |
257 | Nitration | TGMLPANYVEAI--- CCCEEHHHEEEC--- | 11.19 | - | |
257 | Phosphorylation | TGMLPANYVEAI--- CCCEEHHHEEEC--- | 11.19 | 27642862 |
Modified Location | Modified Residue | Modification | Type of Upstream Proteins | Gene Name of Upstream Proteins | UniProt AC of Upstream Proteins | Sources |
---|---|---|---|---|---|---|
146 | S | Phosphorylation | Kinase | CDK7 | P50613 | PhosphoELM |
146 | S | Phosphorylation | Kinase | PRKACA | P17612 | GPS |
146 | S | Phosphorylation | Kinase | PRKG1 | Q13976 | GPS |
146 | S | Phosphorylation | Kinase | PKG1 ISO2 | Q13976-2 | PSP |
146 | S | Phosphorylation | Kinase | PRKG2 | Q13237 | GPS |
146 | S | Phosphorylation | Kinase | PKA-FAMILY | - | GPS |
146 | S | Phosphorylation | Kinase | PKA_GROUP | - | PhosphoELM |
171 | Y | Phosphorylation | Kinase | BCR-ABL1 | A9UF07 | PSP |
171 | Y | Phosphorylation | Kinase | ABL1 | P00519 | GPS |
171 | Y | Phosphorylation | Kinase | LYN | P07948 | PSP |
171 | Y | Phosphorylation | Kinase | SRC | P00523 | PSP |
171 | Y | Phosphorylation | Kinase | SRC | P12931 | PSP |
Modified Location | Modified Residue | Modification | Function | Reference | ||
---|---|---|---|---|---|---|
Oops, there are no descriptions of PTM sites of LASP1_HUMAN !! |
* Distance = the distance between SAP position and PTM sites.
Modified Location | Modification | Variant Position (Distance <= 10) |
Residue Change | SAP | Related Disease | Reference |
---|---|---|---|---|---|---|
Oops, there are no SNP-PTM records of LASP1_HUMAN !! |
Kegg Disease | ||||||
---|---|---|---|---|---|---|
There are no disease associations of PTM sites. | ||||||
OMIM Disease | ||||||
There are no disease associations of PTM sites. | ||||||
Kegg Drug | ||||||
There are no disease associations of PTM sites. | ||||||
DrugBank | ||||||
There are no disease associations of PTM sites. |
loading...
Acetylation | |
Reference | PubMed |
"Lys-N and trypsin cover complementary parts of the phosphoproteome ina refined SCX-based approach."; Gauci S., Helbig A.O., Slijper M., Krijgsveld J., Heck A.J.,Mohammed S.; Anal. Chem. 81:4493-4501(2009). Cited for: ACETYLATION [LARGE SCALE ANALYSIS] AT MET-1, PHOSPHORYLATION [LARGESCALE ANALYSIS] AT THR-104, AND MASS SPECTROMETRY. | |
"Exploring proteomes and analyzing protein processing by massspectrometric identification of sorted N-terminal peptides."; Gevaert K., Goethals M., Martens L., Van Damme J., Staes A.,Thomas G.R., Vandekerckhove J.; Nat. Biotechnol. 21:566-569(2003). Cited for: PROTEIN SEQUENCE OF 1-7, AND ACETYLATION AT MET-1. | |
"Lysine acetylation targets protein complexes and co-regulates majorcellular functions."; Choudhary C., Kumar C., Gnad F., Nielsen M.L., Rehman M., Walther T.,Olsen J.V., Mann M.; Science 325:834-840(2009). Cited for: ACETYLATION [LARGE SCALE ANALYSIS] AT LYS-42 AND LYS-128, AND MASSSPECTROMETRY. | |
Phosphorylation | |
Reference | PubMed |
"A quantitative atlas of mitotic phosphorylation."; Dephoure N., Zhou C., Villen J., Beausoleil S.A., Bakalarski C.E.,Elledge S.J., Gygi S.P.; Proc. Natl. Acad. Sci. U.S.A. 105:10762-10767(2008). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT THR-68; THR-104 AND SER-146,AND MASS SPECTROMETRY. | |
"Phosphoproteome of resting human platelets."; Zahedi R.P., Lewandrowski U., Wiesner J., Wortelkamp S., Moebius J.,Schuetz C., Walter U., Gambaryan S., Sickmann A.; J. Proteome Res. 7:526-534(2008). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-146, AND MASSSPECTROMETRY. | |
"Improved titanium dioxide enrichment of phosphopeptides from HeLacells and high confident phosphopeptide identification by cross-validation of MS/MS and MS/MS/MS spectra."; Yu L.-R., Zhu Z., Chan K.C., Issaq H.J., Dimitrov D.S., Veenstra T.D.; J. Proteome Res. 6:4150-4162(2007). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT THR-68; THR-104 AND SER-151,AND MASS SPECTROMETRY. | |
"Quantitative phosphoproteomic analysis of T cell receptor signalingreveals system-wide modulation of protein-protein interactions."; Mayya V., Lundgren D.H., Hwang S.-I., Rezaul K., Wu L., Eng J.K.,Rodionov V., Han D.K.; Sci. Signal. 2:RA46-RA46(2009). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT THR-68 AND THR-104, AND MASSSPECTROMETRY. | |
"Lys-N and trypsin cover complementary parts of the phosphoproteome ina refined SCX-based approach."; Gauci S., Helbig A.O., Slijper M., Krijgsveld J., Heck A.J.,Mohammed S.; Anal. Chem. 81:4493-4501(2009). Cited for: ACETYLATION [LARGE SCALE ANALYSIS] AT MET-1, PHOSPHORYLATION [LARGESCALE ANALYSIS] AT THR-104, AND MASS SPECTROMETRY. | |
"Quantitative phosphoproteome analysis using a dendrimer conjugationchemistry and tandem mass spectrometry."; Tao W.A., Wollscheid B., O'Brien R., Eng J.K., Li X.-J.,Bodenmiller B., Watts J.D., Hood L., Aebersold R.; Nat. Methods 2:591-598(2005). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT TYR-171, AND MASSSPECTROMETRY. |